Found: 11
Select item for more details and to access through your institution.
Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01110-8
- By:
- Publication type:
- Article
Test-retest reliability of task-based and resting-state blood oxygen level dependence and cerebral blood flow measures.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0206583
- By:
- Publication type:
- Article
Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components.
- Published in:
- Journal of Neuroscience, 2008, v. 28, n. 27, p. 6872, doi. 10.1523/JNEUROSCI.1815-08.2008
- By:
- Publication type:
- Article
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 574, p. 1, doi. 10.1126/scitranslmed.abc2888
- By:
- Publication type:
- Article
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 458, p. 1, doi. 10.1126/scitranslmed.aat7108
- By:
- Publication type:
- Article
A pathophysiological framework of hippocampal dysfunction in ageing and disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 6, p. 764, doi. 10.1001/jamaneurol.2020.0299
- By:
- Publication type:
- Article
How High-Resolution Basal-State Functional Imaging Can Guide the Development of New Pharmacotherapies for Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2009, v. 35, n. 6, p. 1037, doi. 10.1093/schbul/sbp114
- By:
- Publication type:
- Article
Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 3, p. 445, doi. 10.1111/bcp.13466
- By:
- Publication type:
- Article
Linking amyloid to clinical outcome: A quantitative semi‐mechanistic model based on the A/T/N biomarker framework to simulate the natural history of Alzheimer's disease and the effects of anti‐amyloid treatment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.067069
- By:
- Publication type:
- Article